Rockwell Medical, Inc. (RMTI)

NASDAQ: RMTI · IEX Real-Time Price · USD
1.52
0.00 (0.00%)
May 27, 2022 10:33 AM EDT - Market open
Market Cap12.97M
Revenue (ttm)62.58M
Net Income (ttm)-32.08M
Shares Out8.53M
EPS (ttm)-3.76
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume21,396
Open1.52
Previous Close1.52
Day's Range1.50 - 1.58
52-Week Range1.46 - 11.66
Beta1.09
AnalystsBuy
Price Target4.08 (+168.4%)
Earnings DateMay 16, 2022

About RMTI

Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraP...

IndustryHealth Care Equipment & Supplies
IPO DateJan 27, 1998
Employees300
Stock ExchangeNASDAQ
Ticker SymbolRMTI
Full Company Profile

Financial Performance

In 2021, RMTI's revenue was $61.93 million, a decrease of -0.43% compared to the previous year's $62.20 million. Losses were -$32.67 million, 5.78% more than in 2020.

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for RMTI stock is "Buy." The 12-month stock price forecast is 4.08, which is an increase of 168.42% from the latest price.

Price Target
$4.08
(168.42% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Rockwell Medical, Inc. to Present at H.C. Wainwright Annual Global Life Sciences Conference

WIXOM, Mich. , May 23, 2022 /PRNewswire/ -- Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming the treatment of iron defic...

4 days ago - PRNewsWire

Rockwell Medical Provides First Quarter 2022 Financial and Operational Update

- First quarter net sales of $16.1 million, up 4.2% year-over-year -  - Submitted Supplemental Data to FDA for IND Application to enable Phase 2 FPC Home Infusion Trial - - Amended and expanded supply a...

1 week ago - PRNewsWire

Rockwell Medical Submits Additional Data For IND Application For Iron Deficiency Candidate

Rockwell Medical Inc (NASDAQ: RMTI) has provided the FDA with the supplemental data requested by the agency in December 2021 for its pending Investigational New Drug (IND) application of Ferric Pyrophos...

2 weeks ago - Benzinga

Rockwell Medical Submits Supplemental Data to FDA for IND Application for Phase 2 FPC Home Infusion Trial

WIXOM, Mich. , May 12, 2022 /PRNewswire/ -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management, today ann...

2 weeks ago - PRNewsWire

Rockwell Medical Announces 1-for-11 Reverse Stock Split

WIXOM, Mich., May 12, 2022 /PRNewswire/ -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management, today anno...

2 weeks ago - PRNewsWire

Rockwell Medical, Inc. to Report First Quarter 2022 Financial and Operating Results on May 16, 2022

WIXOM, Mich. , May 11, 2022 /PRNewswire/ -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improv...

2 weeks ago - PRNewsWire

Rockwell Medical Announces Completion of Patient Enrollment Ahead of Schedule in Pivotal Phase 3 Clinical Trial of Tr...

Trial with over 400 Patients Conducted by Partner Wanbang Pharmaceuticals, a Subsidiary of Fosun Pharma Over 600,000 Patients receive Hemodialysis in China WIXOM, Mich. , April 25, 2022 /PRNewswire/ -- ...

1 month ago - PRNewsWire

Rockwell Medical to Present at Noblecon18 Investor Conference

WIXOM, Mich. , April 20, 2022 /PRNewswire/ -- Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the "Company"), a biopharmaceutical company dedicated to transforming the treatment of iron def...

1 month ago - PRNewsWire

Best Penny Stocks Today? 4 To Buy For Under $1

Penny stocks under $1 to watch in April 2022 The post Best Penny Stocks Today? 4 To Buy For Under $1 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols:AEISNDLXELA
1 month ago - PennyStocks

Rockwell Medical Expands Partnership with DaVita

$7.5M initial equity investment in Rockwell Amended and expanded supply agreement Strengthens Rockwell's financial position, laying groundwork for improved concentrate business WIXOM, Mich., April 11, 2...

Other symbols:DVA
1 month ago - PRNewsWire

New Survey from Rockwell Medical Reveals Management of Iron Deficiency Anemia in Home Infusion Patients Does Not Adeq...

- Limitations of Currently Available Therapies and Lack of Consensus Guidelines Lead to Suboptimal Treatment of Iron Deficiency Anemia - - Most Survey Respondents Expressed a Preference for an At-Home I...

2 months ago - PRNewsWire

Rockwell Medical Announces Upcoming Poster Presentation at the National Home Infusion Association's 2022 Annual Confe...

WIXOM, Mich., March 09, 2022 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of iron ...

2 months ago - GlobeNewsWire

Rockwell Medical, Inc. to Present at Aegis Virtual Conference

WIXOM, Mich., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of iron d...

3 months ago - GlobeNewsWire

Rockwell Medical Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

WIXOM, Mich., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and im...

3 months ago - GlobeNewsWire

Rockwell Medical Announces Regulatory Approval of Triferic® Dialysate in South Korea

Two product forms of Triferic® are now approved in South Korea Two product forms of Triferic® are now approved in South Korea

4 months ago - GlobeNewsWire

Here Are 3 Penny Stocks You Need to Know About in January

Which penny stocks are on your watchlist right now? The post Here Are 3 Penny Stocks You Need to Know About in January appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols:BBIGPETZ
4 months ago - PennyStocks

Rockwell Medical Shares Surge On South Korean Approval For Iron Supplementation Therapy

Rockwell Medical Inc's (NASDAQ: RMTI) partner, Jeil Pharmaceutical Co Ltd, has received regulatory approval in South Korea for Triferic Injection for iron supplementation therapy and maintaining hemoglo...

4 months ago - Benzinga

Rockwell Medical Announces Regulatory Approval of Triferic® AVNU in South Korea

-Commercial launch expected in June/July 2022-

4 months ago - GlobeNewsWire

Rockwell Medical, Inc. to Present at H.C. Wainwright BioConnect 2022 Conference

WIXOM, Mich., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of iron d...

4 months ago - GlobeNewsWire

Rockwell Medical Receives Important Feedback from FDA on its IND Application for Phase 2 Trial of Ferric Pyrophosphat...

WIXOM, Mich., Dec. 14, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and im...

5 months ago - GlobeNewsWire

Why Are Rockwell Medical Shares Surging Wednesday?

Rockwell Medical Inc (NASDAQ: RMTI) has announced the publication of results in the Journal of Bioequivalence & Bioavailability from a study evaluating the co-administration of intravenous (IV) Ferric P...

6 months ago - Benzinga

Rockwell Medical Study Demonstrates No Drug-drug Interaction Between Ferric Pyrophosphate Citrate and Unfractionated ...

Findings confirm results from previous population PK study demonstrating safe and effective anticoagulation along with the delivery of Ferric Pyrophosphate Citrate iron Findings confirm results from pre...

6 months ago - GlobeNewsWire

Rockwell Medical (RMTI) Reports Q3 Loss, Misses Revenue Estimates

Rockwell Medical (RMTI) delivered earnings and revenue surprises of -14.29% and -11.47%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Recap: Rockwell Medical Q3 Earnings

Rockwell Medical (NASDAQ:RMTI) reported its Q3 earnings results on Monday, November 15, 2021 at 04:00 PM. Here's what investors need to know about the announcement.

6 months ago - Benzinga

Rockwell Medical, Inc. Provides Third Quarter 2021 Financial and Operational Update

- Third quarter net sales of $16.0 Million, up 6% sequential quarter-over-quarter and 5% year-over-year -

6 months ago - GlobeNewsWire